Creo Medical Group Announces Holding Change
The healthcare company has announced a change in its major shareholding, with M&G Plc increasing its stake to over 12%.
The healthcare company has announced a change in its major shareholding, with M&G Plc increasing its stake to over 12%.
The medical device company will announce its interim results and host an online investor presentation.
The medical device company's CFO has transferred a portion of his shareholding to his children.
The medical device company shares a patient testimonial highlighting the benefits of its Speedboat® technology, which helped a patient avoid major surgery.
The medical device company has awarded shares to employees and directors under its Share Incentive Plan.
The medical device company reports 40% growth in core technology revenues in the first half of 2025, in line with expectations, and is tracking on plan for full-year guidance.
The medical device company has commenced a new clinical study evaluating the safety and performance of its MicroBlate™ Flex device for treating lung tumours.
The medical device company has revised the exercise price of options granted to certain PDMRs.
The medical device company has appointed Deutsche Bank AG, London Branch as its new Nominated Adviser and Broker, replacing Numis Securities Limited.
The medical device company provides an update ahead of its AGM, announcing board changes and highlighting progress in its core technology and product pipeline.